Ondansetron in radiation therapy of brain tumor in children.

Autor: Lippens RJ; Center for Pediatric Oncology, University Hospital Nijmegen St. Radboud, The Netherlands., Broeders GC
Jazyk: angličtina
Zdroj: Pediatric hematology and oncology [Pediatr Hematol Oncol] 1996 May-Jun; Vol. 13 (3), pp. 247-52.
DOI: 10.3109/08880019609030823
Abstrakt: Ten children receiving 5 to 6 week courses of radiotherapy after brain tumor surgery were given ondansetron treatment for persistent nausea and emesis. All patients continued the ondansetron treatment until the end of their radiotherapy course. Nausea, emesis, appetite, and adverse events were scored throughout the ondansetron treatment period. Ondansetron was well tolerated by all patients and was effective at reducing symptoms in 60% of the children.
Databáze: MEDLINE